Peripartum Cardiomyopathy in India

Soumya S Patil1, Vidya Jadhav1, Chidanand Chivate2

  • 1Obstetrics and Gynaecology, Bharati Vidyapeeth (Deemed to Be University) Medical College and Hospital, Sangli, IND.

Cureus
|April 27, 2026
PubMed

Background Peripartum cardiomyopathy (PPCM) is characterized by left ventricular systolic dysfunction occurring toward the end of pregnancy or in the months following delivery. In India, delayed recognition due to overlap with physiological pregnancy symptoms often leads to advanced disease at presentation. This study aimed to evaluate the clinical profile, echocardiographic findings, management, and maternal-neonatal outcomes of PPCM cases managed at a tertiary care center. Methodology This retrospective observational study was conducted over three years in the Department of Obstetrics and Gynaecology at a tertiary care center. A total of 11 women fulfilling the European Society of Cardiology diagnostic criteria for PPCM were included. Demographic data, risk factors, clinical presentation, laboratory parameters, echocardiographic findings, management details, and maternal and neonatal outcomes were analyzed using descriptive statistics. Results The mean maternal age was 27.4 ± 6.1 years. Most patients were unbooked referrals (90.9%), and 54.5% presented in the antepartum period. Breathlessness was the predominant symptom (90.9%), with 90.9% presenting in New York Heart Association class III-IV. Preeclampsia was the most common associated risk factor (54.5%). Mean left ventricular ejection fraction (LVEF) at diagnosis was 35.3% (range = 15-45%). Severe left ventricular dysfunction (<30%) was observed in half of the cases. Intensive care unit admission was required in the majority, with mechanical ventilation in 27.3% and cardiogenic shock in 33.3%. Maternal mortality was 9.1%. At six months, 80% of survivors demonstrated recovery of left ventricular function (LVEF >50%), while 20% had persistent dysfunction. Preterm birth occurred in 44.4% of deliveries. Neonatal mortality was 11.1%, and neonatal intensive care unit admission was required in 22.2%. Conclusions PPCM remains an under-recognized yet potentially life-threatening cause of heart failure in pregnancy. Most patients present with severe left ventricular dysfunction but demonstrate significant recovery with timely multidisciplinary management. Increased clinical awareness, early diagnosis, and structured follow-up are essential to improve maternal and neonatal outcomes.

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
813
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
788
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
942
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
750
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
645